Matches in Nanopublications for { ?s ?p "[The aim of this work was to analyse the in vitro reactivity of the soybean cultivar Raiden, which naturally lacks glycinin A(4)A(5)B(3), to evaluate whether this genotype could be a safe CMP substitute for CMA patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 3 of
3
with 100 items per page.
- NP811844.RAQwILwkt6vS8DjnDw3Yjdd4nd3qba2ryuAgxFt-7MB1s130_assertion description "[The aim of this work was to analyse the in vitro reactivity of the soybean cultivar Raiden, which naturally lacks glycinin A(4)A(5)B(3), to evaluate whether this genotype could be a safe CMP substitute for CMA patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP811844.RAQwILwkt6vS8DjnDw3Yjdd4nd3qba2ryuAgxFt-7MB1s130_provenance.
- NP546614.RAYNrSipB-MZp636xiE7H1r6_11ietMIO9j6Ov4FHc4Ro130_assertion description "[The aim of this work was to analyse the in vitro reactivity of the soybean cultivar Raiden, which naturally lacks glycinin A(4)A(5)B(3), to evaluate whether this genotype could be a safe CMP substitute for CMA patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP546614.RAYNrSipB-MZp636xiE7H1r6_11ietMIO9j6Ov4FHc4Ro130_provenance.
- NP682591.RAgopSoN3LGIbtqzb9Y3Wj8EC-xokdpVWUifrMsuL0gAc130_assertion description "[The aim of this work was to analyse the in vitro reactivity of the soybean cultivar Raiden, which naturally lacks glycinin A(4)A(5)B(3), to evaluate whether this genotype could be a safe CMP substitute for CMA patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP682591.RAgopSoN3LGIbtqzb9Y3Wj8EC-xokdpVWUifrMsuL0gAc130_provenance.